作者
Giuseppe Liberatore,Fiore Manganelli,Pietro Emiliano Doneddu,Dario Cocito,Raffaella Fazio,Chiara Briani,Massimiliano Filosto,Luana Benedetti,Anna Teresa Mazzeo,Giovanni Antonini,Giuseppe Cosentino,S. Jann,Andrea Cortese,G Marfia,Angelo Maurizio Clerici,Gabriele Siciliano,M. Carpo,Marco Luigetti,Giuseppe Lauria,Tiziana Rosso,Guido Cavaletti,Lucio Santoro,Erdita Peci,Stefano Tronci,M Ruiz,Stefano Cotti Piccinelli,Angelo Schenone,Luca Leonardi,António Toscano,Giorgia Mataluni,Emanuele Spina,Luca Gentile,Eduardo Nobile‐Orazio
摘要
Abstract Background and purpose The aim was to identify the clinical and diagnostic investigations that may help to support a diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in patients not fulfilling the European Federation of Neurological Societies and Peripheral Nerve Society (EFNS/PNS) electrodiagnostic criteria. Methods The data from patients with a clinical diagnosis of CIDP included in a national database were retrospectively reviewed. Results In all, 535 patients with a diagnosis of CIDP were included. This diagnosis fulfilled the EFNS/PNS criteria in 468 patients (87.2%) (definite in 430, probable in 33, possible in three, while two had chronic immune sensory polyradiculopathy). Sixty‐seven patients had a medical history and clinical signs compatible with CIDP but electrodiagnostic studies did not fulfill the EFNS/PNS criteria for CIDP. These patients had similar clinical features and frequency of abnormal supportive criteria for the diagnosis of CIDP compared to patients fulfilling EFNS/PNS criteria. Two or more abnormal supportive criteria were present in 40 (61.2%) patients rising to 54 (80.6%) if a history of a relapsing course as a possible supportive criterion was also included. Increased cerebrospinal fluid proteins and response to immune therapy most frequently helped in supporting the diagnosis of CIDP. Response to therapy was similarly frequent in patients fulfilling or not EFNS/PNS criteria (87.3% vs. 85.9%). Conclusions Patients with a clinical diagnosis of CIDP had similar clinical findings, frequency of abnormal supportive criteria and response to therapy compared to patients fulfilling EFNS/PNS criteria. The presence of abnormal supportive criteria may help in supporting the diagnosis of CIDP in patients with a medical history and clinical signs compatible with this diagnosis but non‐diagnostic nerve conduction studies.